These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3036018)

  • 1. Influence of antacid and formulation on effectiveness of pancreatic enzyme supplementation in cystic fibrosis.
    Braggion C; Borgo G; Faggionato P; Mastella G
    Arch Dis Child; 1987 Apr; 62(4):349-56. PubMed ID: 3036018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.
    Durie PR; Bell L; Linton W; Corey ML; Forstner GG
    Gut; 1980 Sep; 21(9):778-86. PubMed ID: 7429342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of pancrex V forte and nutrizym in treatment of malabsorption in cystic fibrosis.
    Goodchild MC; Sagaró E; Brown GA; Cruchley PM; Jukes HR; Anderson CM
    Br Med J; 1974 Sep; 3(5933):712-4. PubMed ID: 4606368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
    Gow R; Bradbear R; Francis P; Shepherd R
    Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of L-arginine and sodium bicarbonate in the treatment of malabsorption due to cystic fibrosis.
    Kattwinkel J; Agus SG; Taussig LM; Di Sant'Agnese PA; Laster L
    Pediatrics; 1972 Jul; 50(1):133-7. PubMed ID: 5038088
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo and in vitro studies of microsphere pancreatic supplements.
    Littlewood JM; Kelleher J; Walters MP; Johnson AW
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial of several preparation types of the pancreatic extract Pancrex V in the treatment of cystic fibrosis].
    Braggion C; Mastella G
    Minerva Pediatr; 1985 Nov; 37(21-22):891-6. PubMed ID: 3912659
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of a new semielemental diet in infants with cystic fibrosis.
    Canciani M; Mastella G
    J Pediatr Gastroenterol Nutr; 1985 Oct; 4(5):735-40. PubMed ID: 4045631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four pancreatic extracts in cystic fibrosis.
    Beverley DW; Kelleher J; MacDonald A; Littlewood JM; Robinson T; Walters MP
    Arch Dis Child; 1987 Jun; 62(6):564-8. PubMed ID: 3304172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis.
    Zentler-Munro PL; Assoufi BA; Balasubramanian K; Cornell S; Benoliel D; Northfield TC; Hodson ME
    Pancreas; 1992; 7(3):311-9. PubMed ID: 1594552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.
    Proesmans M; De Boeck K
    Eur J Pediatr; 2003 Nov; 162(11):760-3. PubMed ID: 13680386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008227. PubMed ID: 25310479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of taurine supplementation on fat and energy absorption in cystic fibrosis.
    De Curtis M; Santamaria F; Ercolini P; Vittoria L; De Ritis G; Garofalo V; Ciccimarra F
    Arch Dis Child; 1992 Sep; 67(9):1082-5. PubMed ID: 1417050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approach to pancreatic extract-induced hyperuricosuria in cystic fibrosis.
    Nouisa-Arvanitakis S; Stapleton FB; Linshaw MA; Kennedy J
    J Pediatr; 1977 Feb; 90(2):302-5. PubMed ID: 830926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
    Heijerman HG
    Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
    Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness of a pancreatic enzyme supplement.
    Valerio D; Whyte EH; Schlamm HT; Ruggiero JA; Blackburn GL
    JPEN J Parenter Enteral Nutr; 1981; 5(2):110-4. PubMed ID: 7195437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.